Senior insider sale
Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC. — senior position signals high conviction
$24.01M
360.24K shares
ANZALONE CHRISTOPHER RICHARD plans to sell 360.24K shares of ARROWHEAD PHARMACEUTICALS, INC. valued at approximately $24.01M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Compensation
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/1/2022 | Compensation Compensation | 99.52K | — |
| Total | 99.52K | ||
Completed
Units to sell
51.73K
Market value
$3.58M
Units to sell
12.59K
Market value
$861.4K
Units to sell
13.45K
Market value
$909.6K
Units to sell
85K
Market value
$5.44M
Units to sell
54.30K
Market value
$3.40M
Units to sell
130K
Market value
$8.95M
Planned — Approximate Date
Units to sell
13.19K
Market value
$871.7K
Units
360.24K
Value
$24.01M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/29/2025 | 51.73K | $3.58M | — | Completed |
12/22/2025 | 12.59K | $861.4K | — | Completed |
12/19/2025 | 13.45K | $909.6K | — | Completed |
12/17/2025 | 85K | $5.44M | — | Completed |
12/16/2025 | 54.30K | $3.40M | — | Completed |
12/15/2025 | 130K | $8.95M | — | Completed |
| Planned — Approximate Date | ||||
1/2/2026 | 13.19K | $871.7K | NASDAQ | Planned |
| Total | 360.24K | $24.01M | ||